About the Authors
- Nancy J Sullivan
-
Contributed equally to this work with: Nancy J Sullivan, Thomas W Geisbert
Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
- Thomas W Geisbert
-
Contributed equally to this work with: Nancy J Sullivan, Thomas W Geisbert
Affiliation United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America
- Joan B Geisbert
-
Affiliation United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America
- Devon J Shedlock
-
Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
- Ling Xu
-
Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
- Laurie Lamoreaux
-
Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
- Jerome H. H. V Custers
-
Affiliation Crucell Holland B.V., Leiden, Netherlands
- Paul M Popernack
-
Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
- Zhi-Yong Yang
-
Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
- Maria G Pau
-
Affiliation Crucell Holland B.V., Leiden, Netherlands
- Mario Roederer
-
Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
- Richard A Koup
-
Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
- Jaap Goudsmit
-
Affiliation Crucell Holland B.V., Leiden, Netherlands
- Peter B Jahrling
-
Affiliation Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
- Gary J Nabel
-
*To whom correspondence should be addressed. E-mail: gnabel@nih.gov
Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
Competing Interests
GJN: Intellectual property on gene-based vaccines for Ebola. NJS: Intellectual property on gene-based vaccines for Ebola. ZYY: Intellectual property on gene-based vaccines for Ebola. The company Crucell is developing an Ebola vaccine.
Author Contributions
NJS, TWG, JBG, DJS, LL, and PMP contributed to animal experiments. NJS, DJS, LL, and PMP contributed to immune analyses. NJS, TWG, MGP, MR, RAK, JG, PBJ, and GJN contributed to experimental design. NJS, TWG, MGP, MR, RAK, JG, PBJ, and GJN contributed to data evaluation. NJS, TWG, MGP, PBJ and GJN participated in writing of the paper. LX, JHHVC, ZYY, and MGP contributed to vector construction and production.